4 More London Riverside
+44 283 833 2200
The Almac Group is an established contract development and manufacturing organisation which provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally
The services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IXRS®) through to commercial-scale manufacture.
The international company is a privately owned organisation that has organically grown over almost 50 years and now employs in close to 5,000 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations in the UK, Europe, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo).
Through our continual investment in the development of our state of the art services; from cutting edge biomarker and companion diagnostics through to step changes in the management of the clinical trial data and the clinical supply chain to biocatalytic manufacture of API, Almac ensures we are always there to support you across the product development lifecycle.
North American Headquarters:
25 Fretz Road
T: +1 (215) 660 8500
Almac Pharmaceutical Services Pte. Ltd.
9 Changi South Street 3
Unit 01-01 Singapore
T: +65 63090720
Join #Almac's Richard Kennedy, Global VP of Biomarker Discovery tomorrow, as he sits on an online panel discussion relating to the future of tumor mutational burden (TMB), presented by @OncologyCentral in association with @Illumina. To register: https://t.co/bNAdXjfbFB— Almac Group (@AlmacGroup) March 20, 2019
The #AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research and highlights the work of the best minds in research. Join the #Almac Diagnostics experts at this event! We will be at booth #3225 : https://t.co/jus8O6XY9i @AACR pic.twitter.com/ywYzFWNv1r— Almac Group (@AlmacGroup) March 20, 2019